⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NAGE News
Niagen Bioscience, Inc. Common Stock
Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results
businesswire.com
NAGE
Form 8-K
sec.gov
NAGE
Niagen Bioscience Adds Olympia Pharmaceuticals to 503B Compounding Partner Network for Niagen Plus™
businesswire.com
NAGE
Niagen Bioscience to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026
businesswire.com
NAGE
Niagen Bioscience Collaborates with USP to Establish First-Ever USP Monograph for Nicotinamide Riboside Chloride (NRCl), the Patented Form in Niagen ®
businesswire.com
NAGE
Niagen Bioscience Announces First Cruise Ship Clinic Partnership with OneSpaWorld, Bringing the NAD-Boosting Benefits of Niagen IV to the High Seas
businesswire.com
NAGE
OSW
Form 8-K
sec.gov
ZEOX
NAGE
Form 8-K
sec.gov
NAGE
Niagen Bioscience Increases Share Repurchase Program to $20 Million
businesswire.com
NAGE
Niagen Bioscience Increases Share Repurchase Program to $20 Million
businesswire.com
NAGE